After the devastating Ebola outbreak of 2014, researchers across the globe set out to develop a vaccination that could stop the spread of the deadly virus. One, which is currently being studied and developed by pharmaceutical giant Merck, shows a great deal of promise after a successful trial in Guinea between April and July.

New Ebola Vaccine Shows Promise  New Ebola Vaccine Shows Promise  Continue reading…